{"nctId":"NCT00053846","briefTitle":"Buspirone in Reducing Shortness of Breath in Patients With Cancer","startDateStruct":{"date":"2002-11"},"conditions":["Dyspnea","Pulmonary Complications","Unspecified Adult Solid Tumor, Protocol Specific"],"count":432,"armGroups":[{"label":"buspirone hydrochloride","type":"EXPERIMENTAL","interventionNames":["Drug: buspirone hydrochloride"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"buspirone hydrochloride","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"DISEASE CHARACTERISTICS:\n\n* Diagnosis of cancer\n* Treatment includes the following scenarios:\n\n  * May have had prior chemotherapy course(s)\n  * Scheduled to receive at least 2 courses of chemotherapy\n\n    * Courses may include multiple treatment days such as days 1-5 or day 1-day 8 regimens and may include oral regimens\n* Dyspnea as a symptom within the past 5 days (defined by a score of at least grade 2 on the Modified Medical Research Council Dyspnea Scale)\n\n  * All underlying causes of dyspnea have received medical treatment per best clinical judgement of treating physician\n\nPATIENT CHARACTERISTICS:\n\nAge\n\n* 18 and over\n\nPerformance status\n\n* Eastern Cooperative Oncology Group 0-2\n\nLife expectancy\n\n* Not specified\n\nHematopoietic\n\n* Not specified\n\nHepatic\n\n* Adequate hepatic function (determined by treating oncologist)\n\nRenal\n\n* Adequate renal function (determined by treating oncologist)\n\nCardiovascular\n\n* Adequate cardiac function (determined by treating oncologist)\n\nOther\n\n* Not pregnant or nursing\n* Fertile patients must use effective contraception\n* No history of mania or seizures\n* No prior hospitalization for any psychiatric condition\n* No prior hypersensitivity to buspirone\n* Able to swallow medication\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* Not specified\n\nChemotherapy\n\n* See Disease Characteristics\n\nEndocrine therapy\n\n* Not specified\n\nRadiotherapy\n\n* Concurrent radiotherapy allowed\n\nSurgery\n\n* Not specified\n\nOther\n\n* At least 2 weeks since prior and no concurrent monoamine oxidase inhibitors (MAOIs)\n* Concurrent narcotic medications allowed\n* Concurrent benzodiazepine medications allowed\n* Concurrent serotonin reuptake inhibitors allowed\n* No concurrent alcohol","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"120 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Dyspnea as Measured by Oxygen Cost Diagram (OCD)","description":"OCD was used to evaluate dyspnea on exertion and activities of daily living. OCD is a visual analog scale for quantifying a patient's evaluation of tolerance of exertion, which corresponds to oxygen requirements at different activity levels. It is measured as a score of 2 (sleeping) to 14 (brisk walking uphill). HIgher scores indicate fewer limitations due to dyspnea.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.98","spread":"2.85"},{"groupId":"OG001","value":"9.32","spread":"2.62"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":213},"commonTop":["Dyspnea","Dizziness, confusion; insomnia","Nausea and vomitting","Esophagitis","Shakes and tremors"]}}}